It has been previously observed that most of the COVID-19 patients have very low PCT level, while in admissions to the hospital, markers of inflammation like C-creative proteins (CRP) and biochemical and other biomarkers for the bacterial infections, however, indicated infection in the lungs. This evidence concerns the gene CALCA and COVID-19.